BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

26.45B

Market cap26.45B

Price-Earnings ratio

-32.49

Price-Earnings ratio-32.49

Dividend yield

—

Dividend yield—

Average volume

604.82K

Average volume604.82K

High today

$111.78

High today$111.78

Low today

$109.48

Low today$109.48

Open price

$111.62

Open price$111.62

Volume

616.64K

Volume616.64K

52 Week high

$131.49

52 Week high$131.49

52 Week low

$76.53

52 Week low$76.53

BNTX News

TipRanks 1d

BioNTech Announces Departure of Chief Strategy Officer Ryan Richardson

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

76%

of 25 ratings

Buy

76%

Hold

24%

Sell